هذه المادة حاصلة على موافقة هيئة الدواء المصرية برقم SF0327OA5807 / 032026 تاريخ الانتهاء 16/03/2027 برجاء إبلاغ الإدارة العامة لتنظيم مواد التسويق والإعلان عن أي مواد دعائية أو تعليمية أو توعوية مخالفة لا تحتوي على هذه البيانات من خلال خدمة الإبلاغ عن مواد دعائية دوائية غير ملائمة www.edaegypt.gov.eg
MENU
MENU
LELIPEL (montelukast sodium) is a selective and orally active leukotriene receptor antagonist that specifically inhibits cysteinyl leukotriene CysLT1 receptor.
- Category: Respiratory
- Active Ingredients: Montelukast Sodium
- Action: Selective Leukotrienes receptor antagonist
-
Indications:
- Indicated in the treatment of asthma as add-on therapy in those 6 months to 5 years old patients and older with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom "as-needed" short acting beta agonists provide inadequate clinical control of asthma.
- Indicated in the prophylaxis of asthma from 2 years of age and older in which the predominant component is exercise-induced bronchoconstriction.
- May also be an alternative treatment option to low dose inhaled corticosteroids for 2 to 5 years old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids.
-
Recently Viewed Products
Sleeve High Neck Bodycon Dress
$132.00
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam fringilla augue nec est tristique auctor.
Donec non est at libero.